SCHEMBL15919438

SCHEMBL15919438

CNS(=O)(=O)c1ccc(-c2ccc(-c3cc(C(=O)O)c4cnccc4n3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 8/20 0.53
▸ ALDH1A1 P00352 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ HIF1A Q16665 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ PTGES O14684 1/20 0.46
▸ ALOX5 P09917 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ TP53 P04637 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ PDE10A Q9Y233 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15919436 0.90 PLA2G2A (0.50) DHODHALDH1A1GAAHSD17B10HPGD
SCHEMBL15905449 0.89 ALDH1A1 (0.47) ALDH1A1GAACYP2C9HPGDCYP1A2
Hydrochloric Acid SCHEMBL17313727 0.88 ALDH1A1 (0.46) ALDH1A1GAACYP2C9HPGDCYP1A2
SCHEMBL15919432 0.87 LMNA (0.48) DHODHALDH1A1GAACYP2C9HPGD
SCHEMBL4006546 0.83 DHODH (0.67) DHODHALDH1A1CYP2C9HPGDCYP1A2
SCHEMBL15904966 0.83 ALDH1A1 (0.43) ALDH1A1GAACYP2C9HPGDCYP1A2
SCHEMBL15919431 0.83 ACACB (0.44) ALDH1A1GAACYP2C9CYP1A2CYP2C19
SCHEMBL4248489 0.80 DHODH (0.64) DHODHALDH1A1GAAHIF1AHSD17B10
SCHEMBL4251041 0.79 KDM4E (0.69) DHODHALDH1A1GAAHIF1AHSD17B10
SCHEMBL4245149 0.78 KDM4E (0.64) DHODHALDH1A1GAAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663488-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
US-20150353546-A1 METALLOENZYME INHIBITOR COMPOUNDS Viamet Pharmaceuticals (NC), Inc. 2015-12-10 — — US disclosed
WO-2014117090-A1 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS, INC. (US) 2014-07-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353546-A1 METALLOENZYME INHIBITOR COMPOUNDS MMEL1, GPX1, MPO DHODH 554/4885ALDH1A1 289/4885GAA 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback